Photodiagnosis and Photodynamic Therapy
Volume 3, Issue 3 , Pages 190-201, September 2006

Influence of formulation factors on methyl-ALA-induced protoporphyrin IX accumulation in vivo

  • Ryan F. Donnelly, PhD

      Affiliations

    • School of Pharmacy, Queens University Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast BT9 7BL, UK
    • Department of Radiation Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Montebello 0310, Oslo, Norway
    • Corresponding Author InformationCorresponding author. Tel.: +44 2890 972 251; fax: +44 2890 247 794.
  • ,
  • Petras Juzenas

      Affiliations

    • Department of Radiation Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Montebello 0310, Oslo, Norway
    • Fellow of the Norwegian Cancer Society, P.O. Box 4 Sentrum 0101, Oslo, Norway
  • ,
  • Paul A. McCarron

      Affiliations

    • School of Pharmacy, Queens University Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast BT9 7BL, UK
  • ,
  • Li-Wei Ma

      Affiliations

    • Department of Radiation Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Montebello 0310, Oslo, Norway
  • ,
  • A. David Woolfson

      Affiliations

    • School of Pharmacy, Queens University Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast BT9 7BL, UK
  • ,
  • Johan Moan

      Affiliations

    • Department of Radiation Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Montebello 0310, Oslo, Norway
    • Institute of Physics, University of Oslo, P.O. Box 1048 Blindern 0316, Oslo, Norway

published online 04 May 2006.

Summary 

Photodynamic therapy (PDT) is a medical treatment by which a combination of a photosensitising drug and visible light cause the destruction of selected cells. Thick lesions, such as nodular basal cell carcinomas (BCCs), or lesions with overlying keratinous debris, are reported as being difficult to eradicate using 5-aminolevulinic acid-based photodynamic therapy (ALA-PDT). Such treatment failures have been attributed to the shallow penetration of water-soluble drugs like ALA. In addition, the current scarcity of sophisticated drug delivery research centered on PDT applications has meant that accurate comparison of similar clinical studies is difficult. This paper investigates, for the first time, novel drug delivery systems for controlled drug delivery of methyl-ALA (M-ALA). Pressure sensitive adhesive (PSA) and bioadhesive patches containing defined M-ALA loadings and a standard cream containing equivalent amounts of drug were applied to the skin of mice for defined periods of time and the fluorescence of the protoporphyrin IX (PpIX) induced measured over 24h. Of major importance, the PSA patches containing low drug loadings induced high PpIX levels, which were limited to the site of application, after only 1h applications. Such systems have the potential to improve selectivity of PpIX accumulation, increase simplicity of treatment and, due to the low drug loadings required, reduce costs of clinical PDT. PSA patches would be most suitable for application to areas of dry skin, while bioadhesive patches would be suitable for moist areas, such as the mouth or lower female reproductive tract and have been shown here to induce significant PpIX production at the site of application after 4h applications of patches containing high drug loadings.

Abbreviations: AKs, actinic keratoses, ALA, 5-aminolevulinic acid, BCCs, basal cell carcinomas, CCR, complete clearance rate, PDT, photodynamic therapy, PMVEMA, poly(methylvinylether/maleic anhydride), PpIX, protoporphyrin IX, PSA, pressure sensitive adhesive, TPM, tripropyleneglycol methyl ether

Keywords: 5-Aminolevulinic acid, Drug delivery, Bioadhesion, Patches, Fluorescence

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1572-1000(06)00056-1

doi:10.1016/j.pdpdt.2006.03.007

Photodiagnosis and Photodynamic Therapy
Volume 3, Issue 3 , Pages 190-201, September 2006